HSA — authorised 29 December 1997
- Marketing authorisation holder: ALCON
- Status: likely_approved
HSA authorised Emadine on 29 December 1997
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 29 December 1997.
ALCON holds the Singaporean marketing authorisation.